Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$5.65 - $7.66 $871,631 - $1.18 Million
-154,271 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$4.01 - $6.29 $618,614 - $970,345
-154,268 Reduced 50.0%
154,271 $870,000
Q2 2020

Aug 13, 2020

BUY
$3.06 - $6.6 $944,129 - $2.04 Million
308,539 New
308,539 $1.57 Million

Others Institutions Holding ISEE

About IVERIC bio, Inc.


  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Adams Street Partners LLC Portfolio

Follow Adams Street Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adams Street Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adams Street Partners LLC with notifications on news.